Vetspire Splits From Thrive, Lands a Battery Ventures Backing

A veterinary practice-management vendor just tested whether AI-native software can stand on its own without a strategic parent underwriting it. Battery Ventures is putting a growth investment into Vetspire, and Thrive Pet Healthcare, the multi-site consolidator that has run on Vetspire's platform for years, is stepping away from any ownership stake. The deal lands with a new CEO and a signal worth tracking: institutional money is willing to back veterinary AI as a standalone business, not just a feature bundled inside someone else's roll-up.

Vetspire spins out of Thrive with fresh Battery Ventures capital

Vetspire is an AI-powered practice management platform used by more than 800 veterinary hospitals and clinics across the US and Canada. It handles medical records, scheduling, billing, inventory, and client communications, with an embedded AI scribe and clinical-assistant tools layered on top.

Battery Ventures is providing the growth capital. The investment amount was not disclosed. The firm closed a $3.25B fund in February to back technology companies, and Vetspire is now one of its bets in veterinary software specifically.

Zachary Seely takes over as CEO, arriving from FSI, a healthcare facility-maintenance software company he previously led. Joe Mazzarella stays on as president. Thrive Pet Healthcare, which has used Vetspire's platform across its hospital network, is exiting any ownership position; the company will continue as a customer, but Vetspire now operates as an independent business rather than an asset inside Thrive's structure.

The announcement, via Business Wire on August 13th, quotes Battery general partner Chelsea Stoner calling Vetspire "a forward-thinking, independent provider," and Thrive CEO Tad Stahel confirming the platform "has been the right platform to scale across" Thrive's network. That's the language of a clean, amicable separation, not a forced exit.

Why veterinary software just proved it doesn't need a consolidator parent

The usual direction of travel in veterinary consolidation runs the other way. Multi-site groups like Thrive, NVA, and others have spent years building or buying software so their hospitals run on a system they control, reducing dependence on outside vendors. A consolidator divesting its stake in a software platform, while staying on as a paying customer, is the less common move: it treats the software layer as something better run independently than owned.

That matters for any practice or group currently choosing a practice information management system. An independent, well-capitalized Vetspire has less conflict of interest selling into competing hospital networks than a version of Vetspire still tied to Thrive's balance sheet would. For multi-site operators who compete directly with Thrive for acquisitions and staff, that independence removes a reason to avoid the platform.

It also lands inside a broader AI-in-the-exam-room buildout The Underbite has been tracking. VetRec's expansion into a standalone AI receptionist and its 50-clinic rollout in Australia both point to AI scribe and front-desk tools maturing from add-ons into products vendors will sell on their own. Vetspire's embedded AI scribe puts it in more direct competition with those standalone tools, not just with legacy PIMS incumbents.

The undisclosed investment amount is the piece operators can't yet weigh. A modest check changes the competitive picture less than a nine-figure one would, and until Vetspire or Battery discloses a number, any read on how aggressively Vetspire can now spend against incumbents stays provisional.

There's a procurement angle here too. Practice management systems carry high switching costs: migrating years of medical records, retraining front-desk and clinical staff, and reconfiguring billing integrations all make hospital groups reluctant to change vendors once they're locked in. That inertia has historically favored incumbents and consolidator-owned platforms, since a group already running on its parent company's software has no real choice to make. An independent Vetspire, freed from any single consolidator's roster, can now pitch itself to groups that would have hesitated to adopt software tied to a competing network, widening its addressable buyer pool at the exact moment it has fresh capital to fund a sales push.

What Seely's first moves signal for the AI vet-software field

Seely's background in facility-maintenance software rather than veterinary medicine is worth watching. His mandate, per the announcement, is product innovation and deeper AI capability, the kind of horizontal software-scaling experience Battery likely values more than clinical-domain expertise. How fast Vetspire ships new AI features under his leadership will be the clearest early signal of what the capital is actually funding.

Also worth tracking: whether other software vendors currently embedded inside consolidator networks, in arrangements similar to Vetspire's prior one with Thrive, pursue the same independence path. If institutional investors keep rewarding standalone veterinary AI vendors over consolidator-owned ones, that changes the calculus for any PIMS vendor currently negotiating an ownership stake with a hospital group. And if IDEXX, which competes at the diagnostics-and-software intersection, responds with its own AI-scribe or independence-flavored moves, that would confirm the pattern rather than a one-off deal.

Source: Vetspire via Business Wire